Vaxart, Inc. (VXRT)
NASDAQ: VXRT · IEX Real-Time Price · USD
0.675
-0.009 (-1.26%)
At close: Jul 19, 2024, 4:00 PM
0.673
-0.002 (-0.30%)
Pre-market: Jul 22, 2024, 7:27 AM EDT
Vaxart Revenue
Vaxart had revenue of $8.89M in the twelve months ending March 31, 2024, with 1,174.75% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $2.18M with 223.11% year-over-year growth. In the year 2023, Vaxart had annual revenue of $7.38M with 6,796.26% growth.
Revenue (ttm)
$8.89M
Revenue Growth
+1,174.75%
P/S Ratio
17.28
Revenue / Employee
$81,514
Employees
109
Market Cap
153.51M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7.38M | 7.27M | 6,796.26% |
Dec 31, 2022 | 107.00K | -785.00K | -88.00% |
Dec 31, 2021 | 892.00K | -3.15M | -77.95% |
Dec 31, 2020 | 4.05M | -5.82M | -58.97% |
Dec 31, 2019 | 9.86M | 5.70M | 137.12% |
Dec 31, 2018 | 4.16M | -1.68M | -28.77% |
Dec 31, 2017 | 5.84M | -3.46M | -37.22% |
Jun 30, 2016 | 9.30M | -15.30M | -62.20% |
Jun 30, 2015 | 24.60M | -44.10M | -64.19% |
Jun 30, 2014 | 68.70M | 35.10M | 104.46% |
Jun 30, 2013 | 33.60M | 13.20M | 64.71% |
Jun 30, 2012 | 20.40M | 7.90M | 63.20% |
Jun 25, 2011 | 12.50M | -22.51M | -64.29% |
Dec 25, 2010 | 35.01M | 24.52M | 233.73% |
Dec 26, 2009 | 10.49M | - | - |
Dec 27, 2008 | 0 | - | - |
Dec 29, 2007 | 0 | - | - |
Dec 30, 2006 | 0 | - | - |
Dec 31, 2005 | 0 | - | - |
Dec 25, 2004 | 142.18M | -34.39M | -19.48% |
Dec 27, 2003 | 176.57M | -19.40M | -9.90% |
Dec 28, 2002 | 195.97M | -38.86M | -16.55% |
Dec 29, 2001 | 234.83M | 6.05M | 2.64% |
Dec 30, 2000 | 228.78M | -4.82M | -2.06% |
Dec 31, 1999 | 233.60M | -9.48M | -3.90% |
Dec 31, 1998 | 243.09M | 14.34M | 6.27% |
Dec 31, 1997 | 228.74M | -11.17M | -4.65% |
Dec 31, 1996 | 239.91M | 43.98M | 22.45% |
Dec 31, 1995 | 195.93M | 31.50M | 19.16% |
Dec 31, 1994 | 164.43M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
High Tide | 503.78M |
Assertio Holdings | 142.05M |
Lifecore Biomedical | 103.27M |
OptiNose | 74.02M |
Capricor Therapeutics | 27.10M |
VXRT News
- 4 weeks ago - Vaxart Provides Business Update - GlobeNewsWire
- 5 weeks ago - Vaxart Announces $40 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 5 weeks ago - Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate - GlobeNewsWire
- 2 months ago - Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers - GlobeNewsWire
- 4 months ago - Vaxart to Present at World Vaccine Congress Washington 2024 on April 3 - GlobeNewsWire
- 4 months ago - Vaxart Provides Business Update and Reports Full Year 2023 Financial Results - GlobeNewsWire